Report for Varsha Khokhar(27Y/F)

Tests asked Comprehensive Plus Checkup With Vitamins And Electrolytes, Esr + 1

Others

Test date 05 Jan 2025 Report status Complete Report

Name : VARSHA KHOKHAR(27Y/F) ADDRESS :
Ref. By : SELF
A1 502 SUPERTECH LIVINGSTON CROSSING
REPUBLIK GHAZIABAD LOCALITY:
CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3

Report Availability Summary

Full Report Available
Note : This is summary page. Please refer to the table below for the details

Test Report Status

COMPREHENSIVE PLUS CHECKUP WITH VITAMINS AND ELECTROLYTES Available

25-OH VITAMIN D (TOTAL) Available

CHLORIDE Available

COMPLETE URINE ANALYSIS Available

FASTING BLOOD SUGAR(GLUCOSE) Available

HbA1c Available

HEMOGRAM - 6 PART (DIFF) Available

IRON Available

KIDPRO Available

LIPID PROFILE Available

LIVER FUNCTION TESTS Available

SODIUM Available

TOTAL IRON BINDING CAPACITY (TIBC) Available

TOTAL THYROXINE (T4) Available

TOTAL TRIIODOTHYRONINE (T3) Available

TSH - ULTRASENSITIVE Available

UNSAT.IRON-BINDING CAPACITY(UIBC) Available

VITAMIN B-12 Available

ERYTHROCYTE SEDIMENTATION RATE (ESR) Available

Note : Underlined values are Critical Values, Clinician's attention required. Clinically Tested by : Thyrocare Technologies Ltd.
Name : VARSHA KHOKHAR(27Y/F) ADDRESS :
Ref. By : SELF
A1 502 SUPERTECH LIVINGSTON CROSSING
REPUBLIK GHAZIABAD LOCALITY:
CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3

Report Availability Summary

Full Report Available
Note : This is summary page. Please refer to the table below for the details

Test Report Status

POTASSIUM Available

Note : Underlined values are Critical Values, Clinician's attention required. Clinically Tested by : Thyrocare Technologies Ltd.
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :
REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING
REPUBLIK GHAZIABAD LOCALITY:
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS AND CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3
ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)

H.P.L.C 5.6 %

Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 114 mg/dL

Bio. Ref. Interval. :

90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:12
Report Released on (RRT) : 05 Jan 2025 15:25

Sample Type : EDTA Whole Blood

Labcode : 0501041453/DG871 Dr Eesha Gupta MD(Path)
Barcode : BL036422
Page : 1 of 15
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :

REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING

REPUBLIK GHAZIABAD LOCALITY:
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3
AND ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS

ERYTHROCYTE SEDIMENTATION RATE (ESR) MODIFIED WESTERGREN 11 mm / hr
Bio. Ref. Interval. :-

Male : 0-15 Female : 0-20

Clinical Significance:
- An erythrocyte sedimentation rate (ESR) is a blood test that can rise if you have inflammation in your
body. Its also used as a marker to monitor prognosis of an existing inflammatory/infective condition.
- Inflammation is your immune systems response to injury, infection, and many types of conditions,
including immune system disorders, certain cancers and blood disorders.
- A high ESR test result may be from a condition that causes inflammation, such as: Arteritis, Arthritis,
Systemic vasculitis, Polymyalgia rheumatica, Inflammatory bowel disease, Kidney disease, Infections like
Tuberculosis etc, Rheumatoid arthritis and other autoimmune diseases, Heart disease, Certain cancers and
many other Conditions.
- A low ESR test result may be caused by conditions such as: A blood disorder, such as: Polycythemia, Sickle
cell disease (SCD), Leukocytosis, Heart failure, Certain kidney and liver problems etc.
- Certain physiological conditions also affect ESR results, these include : Pregnancy, menstrual cycle,
ageing, obesity, drinking alcohol regularly, and exercise, Certain medicines and supplements also can
affect ESR results.
- Hence Its always suggested to interpret ESR results in conjunction with Clinical History and other
findings.

References :
https://medlineplus.gov/lab-tests/erythrocyte-sedimentation-rate-esr/

Please correlate with clinical conditions.

Method:- MODIFIED WESTERGREN

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:12
Report Released on (RRT) : 05 Jan 2025 15:25

Sample Type : EDTA Whole Blood

Labcode : 0501041453/DG871 Dr Eesha Gupta MD(Path)

Barcode : BL036422 Page : 2 of 15

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :
REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING
REPUBLIK GHAZIABAD LOCALITY:
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS AND
CROSSINGSREPUBLIK LANDMARK: CITY:
ELECTROLYTES,ESR,POTASSIUM DELHI-3

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 14.2 g/dL 12.0-15.0
Hematocrit (PCV) CPH Detection 43.4 % 36.0-46.0
Total RBC HF & EI 4.96 X 10^6/µL 3.8-4.8
Mean Corpuscular Volume (MCV) Calculated 87.5 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 28.6 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 32.7 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 39.8 fL 39.0-46.0
Red Cell Distribution Width (RDW - CV) Calculated 12.4 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 218.8 - *Refer Note below
MENTZER INDEX Calculated 17.6 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 7.75 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 51.3 % 40-80
Lymphocytes Percentage Flow Cytometry 37.8 % 20-40
Monocytes Percentage Flow Cytometry 5.4 % 2-10
Eosinophils Percentage Flow Cytometry 4.6 % 1-6
Basophils Percentage Flow Cytometry 0.6 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0.0-0.4
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 3.98 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 2.93 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.42 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.05 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.36 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.02 X 10³ / µL 0.0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 319 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 11.2 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 14.5 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 34.8 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.36 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:12
Report Released on (RRT) : 05 Jan 2025 15:25
Sample Type : EDTA Whole Blood
Labcode : 0501041453/DG871 Dr Eesha Gupta MD(Path)
Barcode : BL036422 Page : 3 of 15

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :

REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING

REPUBLIK GHAZIABAD LOCALITY:
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3
AND ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS

FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 85.82 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.

Please correlate with clinical conditions.

Method:- GOD-PAP METHOD

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 13:45

Sample Type : FLUORIDE PLASMA

Labcode : 0501074613/DG871 Dr Eesha Gupta MD(Path)

Barcode : BD582800 Page : 4 of 15

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :
REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS AND REPUBLIK GHAZIABAD LOCALITY:
CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3
ELECTROLYTES,ESR,POTASSIUM

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.01 - 1.003-1.030
PH pH indicator 5.5 - 5-8
Chemical Examination
URINARY PROTEIN PEI ABSENT mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction ABSENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy ABSENT cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy ABSENT cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy ABSENT - Absent
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT - Absent
PARASITE Microscopy ABSENT - Absent

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 14:08
Report Released on (RRT) : 05 Jan 2025 16:31
Sample Type : URINE
Labcode : 0501079969/DG871 Dr Eesha Gupta MD(Path)

Barcode : BL056404 Page : 5 of 15

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :

REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING

REPUBLIK GHAZIABAD LOCALITY:
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3
AND ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 5.53 ng/mL
Bio. Ref. Interval. :-

Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml

Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are
critical for building bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.

Please correlate with clinical conditions.

Method:- Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 15:58

Sample Type : SERUM

Labcode : 0501074750/DG871 Dr Eesha Gupta MD(Path)

Barcode : BL026334 Page : 6 of 15

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :

REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING

REPUBLIK GHAZIABAD LOCALITY:
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3
AND ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS

VITAMIN B-12 E.C.L.I.A 331 pg/mL
Bio. Ref. Interval. :-

Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat,
eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin
sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic
anemias. For diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical
examination and other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st
Edition,TH Books-Verl-Ges,1998:424-431

Please correlate with clinical conditions.

Method:- Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 15:58

Sample Type : SERUM

Labcode : 0501074750/DG871 Dr Eesha Gupta MD(Path)

Barcode : BL026334 Page : 7 of 15

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :
REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING
REPUBLIK GHAZIABAD LOCALITY:
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS AND CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3
ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 124 µg/dL

Bio. Ref. Interval. :

Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 380 µg/dL

Bio. Ref. Interval. :

Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl

Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 33 %

Bio. Ref. Interval. :

13 - 45
Method : Derived from IRON and TIBC values

UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 256.8 µg/dL

Bio. Ref. Interval. :

162 - 368
Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 15:58

Sample Type : SERUM

Labcode : 0501074750/DG871 Dr Eesha Gupta MD(Path)
Barcode : BL026334
Page : 8 of 15
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :
REF. BY A1 502 SUPERTECH LIVINGSTON CROSSING REPUBLIK
: SELF
GHAZIABAD LOCALITY: CROSSINGSREPUBLIK
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS ANDLANDMARK: CITY: DELHI-3
ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 164 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 42 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 105.48 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 80 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 3.9 Ratio 3-5
TRIG / HDL RATIO CALCULATED 1.93 Ratio < 3.12
LDL / HDL RATIO CALCULATED 2.5 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.4 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 121.95 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 16.1 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :

CHOL - Cholesterol Oxidase, Esterase, Peroxidase

HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values

*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:

TOTAL CHOLESTEROL LDL (mg/dl) TRIGLYCERIDES

(mg/dl) HDL (mg/dl) (mg/dl)

DESIRABLE <200 LOW OPTIMAL <100 NORMAL <150

<40

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199

HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499

HIGH 160-189 VERY HIGH >500

VERY HIGH >190

Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 15:58

Sample Type : SERUM

Labcode : 0501074750/DG871 Dr Eesha Gupta MD(Path)

Barcode : BL026334
Page : 9 of 15
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :
REF. BY A1 502 SUPERTECH LIVINGSTON CROSSING REPUBLIK
: SELF
GHAZIABAD LOCALITY: CROSSINGSREPUBLIK
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS ANDLANDMARK: CITY: DELHI-3
ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 114.36 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.64 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.56 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 45.08 U/L < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.16 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 50.18 U/L < 34
SGOT / SGPT RATIO CALCULATED 0.66 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.91 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 3.99 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.92 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.02 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :

ALKP - Modified IFCC method

BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 15:58

Sample Type : SERUM

Labcode : 0501074750/DG871 Dr Eesha Gupta MD(Path)

Barcode : BL026334
Page : 10 of 15
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :
REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING
REPUBLIK GHAZIABAD LOCALITY:
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS AND CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3
ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS

SODIUM I.S.E - INDIRECT 138 mmol/L

Bio. Ref. Interval. :

Adults: 136-145 mmol/l

Method : ION SELECTIVE ELECTRODE - INDIRECT

CHLORIDE I.S.E - INDIRECT 103.8 mmol/L

Bio. Ref. Interval. :

ADULTS: 98-107 MMOL/L

Clinical Significance :
An increased level of blood chloride (called hyperchloremia) usually indicates dehydration, but can also occur with other problems that
cause high blood sodium, such as Cushing syndrome or kidney disease. Hyperchloremia also occurs when too much base is lost from the
body (producing metabolic acidosis) or when a person hyperventilates (causing respiratory alkalosis). A decreased level of blood chloride
(called hypochloremia) occurs with any disorder that causes low blood sodium. Hypochloremia also occurs with congestive heart failure,
prolonged vomiting or gastric suction, Addison disease, emphysema or other chronic lung diseases (causing respiratory acidosis), and
with loss of acid from the body (called metabolic alkalosis).
Method : ION SELECTIVE ELECTRODE - INDIRECT

POTASSIUM I.S.E - INDIRECT 4.94 mmol/L

Bio. Ref. Interval. :

ADULTS: 3.5-5.1 MMOL/L

Clinical Significance :
An abnormal increase in potassium (hyperkalemia)can profoundly affect the nervous system and increase the chance of irregular
heartbeats (arrhythmias), which ,when extreme ,can be fatal. The assay could be affected mildly and may result in anomalous values if
serum samples have heterophilic antibodies, hemolyzed , icteric or lipemic. The concentration of Potassium in a given specimen may vary
due to differences in assay methods, calibration and reagent specificity.
Method : ION SELECTIVE ELECTRODE - INDIRECT

Please correlate with clinical conditions.

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 15:58

Sample Type : SERUM

Labcode : 0501074750/DG871 Dr Eesha Gupta MD(Path)
Barcode : BL026334
Page : 11 of 15
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :
REF. BY A1 502 SUPERTECH LIVINGSTON CROSSING REPUBLIK
: SELF
GHAZIABAD LOCALITY: CROSSINGSREPUBLIK
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS ANDLANDMARK: CITY: DELHI-3
ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 9.07 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.6 mg/dL 0.55-1.02
BUN / Sr.CREATININE RATIO CALCULATED 15.12 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 19.41 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 32.35 Ratio < 52
CALCIUM PHOTOMETRY 9.69 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 4.3 mg/dL 3.2 - 6.1
Please correlate with clinical conditions.

Method :

BUN - Kinetic UV Assay.

SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 15:58

Sample Type : SERUM

Labcode : 0501074750/DG871 Dr Eesha Gupta MD(Path)

Barcode : BL026334
Page : 12 of 15
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :
A1 502 SUPERTECH LIVINGSTON CROSSING REPUBLIK
REF. BY : SELF
GHAZIABAD LOCALITY: CROSSINGSREPUBLIK
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS AND LANDMARK: CITY: DELHI-3
ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 117 ng/dL 80-200

TOTAL THYROXINE (T4) E.C.L.I.A 8.81 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 2.62 µIU/mL 0.54-5.30

Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :
T3 - Fully Automated Electrochemiluminescence Compititive Immunoassay
T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay
USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay
Pregnancy reference ranges for TSH/USTSH :
Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor reclassified as Benign. Acta
Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones in Indian women
with normal pregnancy : New light through old window. Indian Journal of Contemporary medical research. 2019; 6(4)
Disclaimer :

Results should always be interpreted using the reference range provided by the laboratory that performed the test.
Different laboratories do tests using different technologies, methods and using different reagents which may cause difference
In reference ranges and hence it is recommended to interpret result with assay specific reference ranges provided in the reports.
To diagnose and monitor therapy doses, it is recommended to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 15:58
Sample Type : SERUM
Labcode : 0501074750/DG871 Dr Eesha Gupta MD(Path)
Barcode : BL026334 Page : 13 of 15

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
 NAME : VARSHA KHOKHAR(27Y/F) HOME COLLECTION :

REF. BY : SELF A1 502 SUPERTECH LIVINGSTON CROSSING

REPUBLIK GHAZIABAD LOCALITY:
TEST ASKED : COMPREHENSIVE PLUS CHECKUP WITH VITAMINS CROSSINGSREPUBLIK LANDMARK: CITY: DELHI-3
AND ELECTROLYTES,ESR,POTASSIUM

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 125 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine Equation

~~ End of report ~~

Sample Collected on (SCT) : 05 Jan 2025 09:33

Sample Received on (SRT) : 05 Jan 2025 13:04
Report Released on (RRT) : 05 Jan 2025 15:58

Sample Type : SERUM

Labcode : 0501074750/DG871 Dr Eesha Gupta MD(Path)

Barcode : BL026334 Page : 14 of 15

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Docon Technologies Private Limited,Thyrocare Technologies Limited and its employees/representatives do not
assume any liability,responsibility for any loss or damage that may be incurred by any person as a result of
presuming the meaning or contents of the report.

EXPLANATIONS

v Name - The name is as declared by the client and recorded by the personnel who collected the specimen.
v Ref.By - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing the
barcode (irrespective of the name).
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v For suggestions, complaints or feedback, write to us at [email protected] or call us on 7022000900.

Page : 15 of 15